Chronic lymphocytic leukemia often arises by a multiclonal selection process


Por: Bagnara, D, Mazzarello, AN, Cardente, N, Vergani, S, Kasar, S, Fernandes, S, Ferrer, G, Ghiotto, F, Barrientos, JC, Kolitz, JE, Rai, KR, Allen, SL, Colombo, M, Fais, F, Brown, JR, Ferrarini, M and Chiorazzi, N

Publicada: 1 ago 2025 Ahead of Print: 20 feb 2025
Resumen:
Although chronic lymphocytic leukemia (CLL) is diagnosed by identifying a circulating B-cell clone that exceeds 5x103/mu L, additional distinct clones (ADC) have been identified in various studies. Notably, the numbers of ADC documented in these studies has increased as the various technologies evolved. To better define the frequency and the characteristics of ADC in CLL, we used a next-generation sequencing platform that affords high sequencing depth along with steps that limit over-counting to analyze IGHV-IGHD-IGHJ gene rearrangements in circulating CD5+ B cells from 57 patients. Notably, all patients had at least one ADC, in addition to the clinically relevant clone. In 46 patients for whom lymphocyte count data were available, 44 had at least one ADC above the threshold of 1 B cell/mu L and, remarkably, the average number of ADC was 12 per patient. Notably, in two patients, the predominant ADC qualified clinically as a separate CLL clone and in the remaining cases as low/high-count monoclonal B-cell lymphocytosis clones. Moreover, in 11 patients studied longitudinally, predominant ADC were persistent and often increased in number. ADC in patients with CLL exhibited 4-fold more stereotyped IGHV-IGHD-IGH rearrangements than found in CD5+ B cells from healthy individuals, and IGHV use, somatic mutations, and Ig isotype distribution were similar between predominant ADC and clinically relevant clones. Thus, finding multiple expanded clones within the CD5+ B cells is the rule in patients with CLL, indicating that leukemogenesis is a multiclonal process that likely involves competition among B cells with special B-cell receptor features.

Filiaciones:
Bagnara, D:
 Univ Genoa, Dept Expt Med, Genoa, Italy

 Northwell Hlth, Feinstein Inst Med Res, Karches Ctr Oncol Res, Manhasset, NY 11030 USA

Mazzarello, AN:
 Univ Genoa, Dept Expt Med, Genoa, Italy

 Northwell Hlth, Feinstein Inst Med Res, Karches Ctr Oncol Res, Manhasset, NY 11030 USA

Cardente, N:
 Univ Genoa, Dept Expt Med, Genoa, Italy

Vergani, S:
 Northwell Hlth, Feinstein Inst Med Res, Karches Ctr Oncol Res, Manhasset, NY 11030 USA

 Miltenyi Botec BV & Co KG, Bergisch Gladbach, Germany

Kasar, S:
 Dana Farber Canc Inst, CLL Ctr, Boston, MA USA

 Harvard Med Sch, Boston, MA USA

 Takeda Pharmaceut, Cambridge, MA USA

Fernandes, S:
 Dana Farber Canc Inst, CLL Ctr, Boston, MA USA

 Harvard Med Sch, Boston, MA USA

:
 Northwell Hlth, Feinstein Inst Med Res, Karches Ctr Oncol Res, Manhasset, NY 11030 USA

 Josep Carreras Leukaemia Res Inst IJC, Badalona, Spain

 Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain

Ghiotto, F:
 Univ Genoa, Dept Expt Med, Genoa, Italy

 IRCCS Osped Policlin San Martino, Genoa, Italy

Barrientos, JC:
 Northwell Hlth, Feinstein Inst Med Res, Karches Ctr Oncol Res, Manhasset, NY 11030 USA

 Zucker Sch Med Hofstra Northwell, Dept Mol Med, Hempstead, NY USA

 Zucker Sch Med Hofstra Northwell, Dept Med, Hempstead, NY USA

Kolitz, JE:
 Northwell Hlth, Feinstein Inst Med Res, Karches Ctr Oncol Res, Manhasset, NY 11030 USA

 Zucker Sch Med Hofstra Northwell, Dept Mol Med, Hempstead, NY USA

 Zucker Sch Med Hofstra Northwell, Dept Med, Hempstead, NY USA

Rai, KR:
 Northwell Hlth, Feinstein Inst Med Res, Karches Ctr Oncol Res, Manhasset, NY 11030 USA

 Zucker Sch Med Hofstra Northwell, Dept Mol Med, Hempstead, NY USA

 Zucker Sch Med Hofstra Northwell, Dept Med, Hempstead, NY USA

Allen, SL:
 Northwell Hlth, Feinstein Inst Med Res, Karches Ctr Oncol Res, Manhasset, NY 11030 USA

 Zucker Sch Med Hofstra Northwell, Dept Mol Med, Hempstead, NY USA

 Zucker Sch Med Hofstra Northwell, Dept Med, Hempstead, NY USA

Colombo, M:
 IRCCS Osped Policlin San Martino, Genoa, Italy

Fais, F:
 Univ Genoa, Dept Expt Med, Genoa, Italy

 IRCCS Osped Policlin San Martino, Genoa, Italy

Brown, JR:
 Dana Farber Canc Inst, CLL Ctr, Boston, MA USA

 Harvard Med Sch, Boston, MA USA

Ferrarini, M:
 Univ Genoa, Dept Expt Med, Genoa, Italy

Chiorazzi, N:
 Northwell Hlth, Feinstein Inst Med Res, Karches Ctr Oncol Res, Manhasset, NY 11030 USA

 Zucker Sch Med Hofstra Northwell, Dept Mol Med, Hempstead, NY USA

 Zucker Sch Med Hofstra Northwell, Dept Med, Hempstead, NY USA
ISSN: 03906078





HAEMATOLOGICA
Editorial
Ferrata Storti Foundation, VIA GIUSEPPE BELLI 4, 27100 PAVIA, ITALY, Italia
Tipo de documento: Article
Volumen: 110 Número: 8
Páginas: 1747-1757
WOS Id: 001547246400011
ID de PubMed: 39973373
imagen Green Submitted, gold

MÉTRICAS